Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06702631Phase 1Completed
Phase 1, open-label, single-arm trial of nitrous oxide in pain. Primary endpoints: Brain activation to painful stimulation difference and Resting-state functional connectivity difference. Started Jan 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06702631.